Bob Lederer RFL Communications, Inc.

Mark Penn’s Microsoft role includes competitive intelligence & analysis; Business Analysts receive new data merging analysis tool, called Paxata; Ipsos’ view of 2014 changes in market research industry; Lowe’s hires Chief Customer Officer (RBDR–3/6/2014)

Sponsored today and this week by Toluna (http://www.toluna.com), bringing people and brands together in the world’s largest social voting community.

Today: 1) Seattle Times technology reporter Janet Tu sheds light on new Microsoft Chief Strategy Officer Mark Penn’s specific responsibilities. 2) You will be hearing a lot about Paxata, a brand new system that IN MINUTES combines different types of data that every business analyst needs to combine for analysis. 3) Ipsos reports its 2013 revenues and profits, and explains changes it sees for 2014 market research for vendors. 4) Lowe’s hires a Chief Customer Officer.

Bob Lederer RFL Communications, Inc.

Expert tips on hiring top analytic talent; Surprising Super Bowl #1 commercial winner; PHEME: a system to identify & dispel social media rumors (RBDR–3/5/2014)

Sponsored today and this week by Toluna (http://www.toluna.com), bringing people and brands together in the world’s largest social voting community.

Today: 1) Three MR industry experts blog about how to find and hire needed analytic talent. 2) Socratic Technologies releases results of its 2014 Super Bowl commercial study, which surprisingly found WeatherTech as the top performer. 3) Microsoft elevated Mark Penn to Chief Strategy Officer, but without specific public responsibilities. The Alliance for Audited Media hired its new CEO, President and Managing Director, Tom Drouillard. 4) Five European universities are cooperating to attempt to develop a system, funded by the EU, that can identify the source of a rumor in social media comes and whether it can be verified.

Bob Lederer RFL Communications, Inc.

IBM Watson tech offered to mobile developers; How CMO & CIO help MR; Bill Harvey discusses pervasiveness of mobile devices (RBDR–3/4/2014)

Sponsored today and this week by Toluna (http://www.toluna.com), bringing people and brands together in the world’s largest social voting community.

Today: 1) The IBM Watson Mobile Developer Challenge is underway, a global opportunity for mobile app developers to create new ones that use the IBM Watson cognitive innovation. 2) Mary Shacklett’s thought piece on corporate CMO-CIO collaborations makes three points that underscore MR’s dependency on other departments. 3) Bill Harvey discusses data and other elements that portray the impotence of second screen with TV viewing.

Bob Lederer RFL Communications, Inc.

Three professors endorse Conjoint Analysis for exit polling; Millward Brown & ZappiStore roll out 6-hour, DIY copy testing; 48% of U.S. population is “Always-On” (RBDR–3/3/2014)

Sponsored today and this week by Toluna (http://www.toluna.com), bringing people and brands together in the world’s largest social voting community.

Today: 1) Professors from MIT, Stanford and Georgetown have authored a paper that endorses the use of conjoint analysis to bring important understanding to exit polling. 2) Millward Brown’s new DIY eStatic service allows users to conduct self-service print and advertising copy-testing in six hours. 3) Vivaldi Partners’ Always-On 2014 Digital Consumer Report says 48% of the U.S. population has at least 3 digital devices that they use from at least three different physical locations multiple times each day.

Bob Lederer RFL Communications, Inc.

Comparing Observational MR; Proposed Part D changes; FDA generic Rx initiative; HIMSS reports on HC mobile implementation vs. usage; MDLinx verifying European MDs; Novartis expands clinical data transparency; SAP testing “Medical Insights” cancer patient assistance (PMRVR–3/4/14)

In this Pharma Market Research VIDEO Report:  1) GRACE, an 11-item checklist of data and methods, allows testing of baseline quality criteria for observational research.  2) The CMS is proposing changes to Medicare Part D. The big picture change calls for stopping automatic Medicare coverage of two drug classes; the underlying consideration in the plan could lead to federal government price negotiations with pharmacos (expressly forbidden in legislation that established Part D).  3) The FDA launches a $20 million initiative to test generic drug production, which represents 80% of Rx drugs. India, wiht its $15 billion in annual generic drug production, is a primary focus but China is also in the crosshairs. 4) HIMSS mobile research study investigates its implementation and use by healthcare providers.  5) GfK reports an upsurge in 2013 in purchase of mobile-connected medical devices in top European countries.  6) MDLinx is launching its physician verification service in Europe.  7) The Kaiser Family Foundation reports users of the ACA website were more price-oriented than physician-focused.  8) Novartis says it has extended its pharmaco leadership in clinical trial data transparency.  9) SAP is testing “Medical Insights,” a capability that aids cancer patients by pulling relevant data from many cancer data sources, runs advanced analytics and delivers customized results in real time.